簡單說，在這段期間兒童點用Atropine的比例增加了，主要在低濃度部分。原因也許跟教育部的視力篩檢計畫有關。9~12歲、住在大都市及父母社經地位較高的兒童有較高的點用機會。長期點用的副作用及13-18歲兒童點用的研究需要被進一步進行。
------------------------------------------------------
近視是一嚴重的世界性健康問題，而在台灣，近視的高比例及嚴重程度更是居於全球領先地位。控制近視增加的方法有很多，其中Atropine在台灣地區是眼科醫師日常處置近視兒童的一種方式，但這在其他國家並不常見。
作者分析2000年到2007年全民健康保險局的資料庫，試圖呈現台灣4到18歲兒童及青少年點用Atropine的情況。
結果顯示，兒童求診眼科的比例，在這期間增加了68.3%，而被診斷為近視的兒童中，處方Atropine的比例也提升了34%，處方高濃度(0.5% & 1%)的比例下降，而處方低濃度(0.3%、0.25% & 0.1%)的比例則明顯提高。
進一步分析發現，眼科求診的人數增加，也許是跟教育部的健康促進實施計畫的視力篩檢有關。另外點用Atropine的兒童年齡以9~12歲的比例最高，城鄉的部分以大都市點用機會較高，社經地位以高收入者點用機會較高。
作者最後提出，有關長期點用的副作用及13-18歲兒童點用的研究需要被進一步進行。
原文如下
Eye (Lond). 2013 Mar;27(3):418-24. doi: 10.1038/eye.2012.279. Epub 2013 Jan 4.
Prescription of atropine eye drops among children diagnosed with myopia in Taiwan from 2000 to 2007: anationwide study.
Source
Institute of Health and Welfare Policy, National Yang-Ming University, Taipei, Taiwan.
Abstract
PURPOSE:
This study was conducted to examine the atropine eye drop prescription trend for children diagnosed with myopia, and to determine the factors associated with the prescription of atropine eye drops.
DESIGN:
This was a population-based cross-sectional study.
METHODS:
This study was conducted using a national representative sample from the National Health Insurance (NHI) claims data. All school childrenbetween 4 and 18 years of age who had visited an ophthalmologist and were diagnosed with myopia between 2000 and 2007 were included herein. The main outcome measure was the proportion of subjects who were prescribed atropine eye drops in each year. Logistic regression was used to identify the factors associated with atropine eye drops being prescribed.
RESULTS:
The prescription of atropine eye drops for children diagnosed with myopia increased significantly from the school years 2000 (36.9%) to 2007(49.5%). There was also a shift from prescribing high concentrations (0.5 and 1%) of atropine eye drops to lower concentration ones (0.3, 0.25, and 0.1%) within this period. Atropine eye drops were more frequently prescribed to 9-12-year-old children (OR=1.26-1.42, compared with those 7-8 years old), and tochildren from families with a high socioeconomic status (OR=1.19-1.25); however, they were less prescribed to those living in mid to low urbanized areas (OR=0.65-0.84).
CONCLUSIONS:
This study revealed an increasing trend of atropine eye drop prescription for children with myopia in Taiwan. Our study provides eye-care professionals worldwide a reference for the potential integration of atropine eye drops into their clinical practice toward children with myopia.
- PMID:
- 23288141
- [PubMed - indexed for MEDLINE]
- PMCID:
- PMC3597881
- [Available on 2014/3/1]
